Home > Cashflow Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹120 Cr₹800 Cr₹1,814 Cr₹-2,969 Cr₹-1,365 Cr

What is the latest Cash Flow from Financing Activities ratio of AUROBINDO PHARMA ?

The latest Cash Flow from Financing Activities ratio of AUROBINDO PHARMA is ₹120 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹120 Cr
Mar2024₹800 Cr
Mar2023₹1,814 Cr
Mar2022₹-2,969 Cr
Mar2021₹-1,365 Cr

How is Cash Flow from Financing Activities of AUROBINDO PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹120 Cr
-85.04
Mar2024 ₹800 Cr
-55.89
Mar2023 ₹1,814 Cr
Positive
Mar2022 ₹-2,969 Cr
Negative
Mar2021 ₹-1,365 Cr -

Compare Cash Flow from Financing Activities of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹65,813.4 Cr -2.9% -6.9% -4.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹391,488.0 Cr -2.5% -7% -8% Stock Analytics
DIVIS LABORATORIES ₹159,415.0 Cr -2.2% -7.2% 1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹132,906.0 Cr -4% 2.8% 27.1% Stock Analytics
CIPLA ₹106,210.0 Cr -5.5% -12.4% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹103,089.0 Cr 5.9% -3.7% -6.5% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-2.9%

-6.9%

-4.8%

SENSEX

-2.4%

-4.7%

6.4%


You may also like the below Video Courses